OXY three-lens brief
Evidence-based stock research on OXY. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 8.2pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 8.2pp over 30 days.
- P/E of 71 — priced for high growth; little margin of safety.
- Analyst mean target $65.22 — 24% above current (23 analysts).
- Earnings scheduled 2026-08-05.
OXY closed at $52.45 (+0.29%) as of 2026-07-10. Market cap: $52.17B. P/E (trailing) 70.9. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $65.22 — 24% above current (23 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 8.2pp over 30 days.. Last quarter: Revenue $5.11B, net income $3.17B, free cash flow $3.03B. Watching for: 2026-08-05 earnings release (25 days out).
Why three lenses on OXY, not one.
A single reasoning model has blind spots it doesn’t know about. We examine OXYacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/OXY" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath OXY brief"></iframe>